Open-Label, Randomized, Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers

Condition:   Human Gastrointestinal Physiology Data Interventions:   Drug: Glucotrol XL 5Mg Extended-Release Tablet;   Drug: Glipizide ER 5 MG 24 HR Extended Release Oral Tablet;   Drug: Rifaximin 200Mg Tab;   Drug: 13C6-Glipizide Sponsors:   University of Michigan;   Food and Drug Administration (FDA) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials